Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) EPS (Weighted Average and Diluted) (2021 - 2025)

Tenon Medical has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at -$0.22 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 103.0% year-over-year to -$0.22; the TTM value through Dec 2025 reached -$1.99, up 86.25%, while the annual FY2025 figure was -$1.7, 84.9% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.22 at Tenon Medical, up from -$0.4 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $7.34 in Q4 2024 and troughed at -$3311.9 in Q2 2023.
  • A 5-year average of -$176.71 and a median of -$2.01 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 509419.6% in 2023 and later skyrocketed 234.43% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$2.96 in 2021, then surged by 73.99% to -$0.77 in 2022, then crashed by 609.09% to -$5.46 in 2023, then surged by 234.43% to $7.34 in 2024, then crashed by 103.0% to -$0.22 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for TNON at -$0.22 in Q4 2025, -$0.4 in Q3 2025, and -$0.36 in Q2 2025.